Ivermectin exhibits potent anti-mitotic activity

Veterinary Parasitology

Volumn 226, Issue , 2016, Pages 1-4

  Ashraf, Shoaib ^a   Prichard, Roger ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Anti mitotic; Ivermectin; Mammalian tubulin

Indexed keywords

IVERMECTIN; TUBULIN; ANTIMITOTIC AGENT; ANTIPARASITIC AGENT;

ANTIMITOTIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIVISION; COLD; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN POLYMERIZATION; TUBULIN POLYMERIZATION ASSAY; CHEMISTRY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; MICROTUBULE; MITOSIS; POLYMERIZATION;

ANTIMITOTIC AGENTS; ANTIPARASITIC AGENTS; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IVERMECTIN; MICROTUBULES; MITOSIS; POLYMERIZATION; TUBULIN;

EID: 84976292944     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2016.06.015     Document Type: Article

References (16)

1. Ashraf, S., Beech, R.N., Hancock, M.A., Prichard, R.K., Ivermectin binds to Haemonchus contortus tubulins and promotes stability of microtubules. Int. J. Parasitol. 45 (2015), 647–654.
2. Ashraf, S., Mani, T., Beech, R., Prichard, R., Macrocyclic lactones and their relationship to the SNPs related to benzimidazole resistance. Mol. Biochem. Parasitol. 201 (2015), 128–134.
3. Baraka, O.Z., Mahmoud, B.M., Marschke, C.K., Geary, T.G., Homeida, M.M., Williams, J.F., Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus. Eur. J. Clin. Pharmacol. 50 (1996), 407–410.
4. Cully, D.F., Vassilatis, D.K., Liu, K.K., Paress, P.S., Van der Ploeg, L.H., Schaeffer, J.M., Arena, J.P., Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371 (1994), 707–711.
5. Dadarkar, S.S., Deore, M.D., Gatne, M.M., Comparative evaluation of acute toxicity of ivermectin by two methods after single subcutaneous administration in rats. Regul. Toxicol. Pharmacol. 47 (2007), 257–260.
6. Drinyaev, V.A., Mosin, V.A., Kruglyak, E.B., Novik, T.S., Sterlina, T.S., Ermakova, N.V., Kublik, L.N., Levitman, M., Shaposhnikova, V.V., Korystov, Y.N., Antitumor effect of avermectins. Eur. J. Pharmacol. 501 (2004), 19–23.
7. Geary, T.G., Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. 21 (2005), 530–532.
8. Guzzo, C.A., Furtek, C.I., Porras, A.G., Chen, C., Tipping, R., Clineschmidt, C.M., Sciberras, D.G., Hsieh, J.Y., Lasseter, K.C., Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J. Clin. Pharmacol. 42 (2002), 1122–1133.
9. Jordan, M.A., Wilson, L., Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4 (2004), 253–265.
10. Kobylinski, K.C., Foy, B.D., Richardson, J.H., Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae. Malar. J., 11, 2012, 381.
11. Korystov, Y.N., Ermakova, N.V., Kublik, L.N., Levitman, M., Shaposhnikova, V.V., Mosin, V.A., Drinyaev, V.A., Kruglyak, E.B., Novik, T.S., Sterlina, T.S., Avermectins inhibit multidrug resistance of tumor cells. Eur. J. Pharmacol. 493 (2004), 57–64.
12. Lim, L.E., Vilcheze, C., Ng, C., Jacobs, W.R. Jr., Ramon-Garcia, S., Thompson, C.J., Anthelmintic avermectins kill Mycobacterium tuberculosis, including multidrug-resistant clinical strains. Antimicrob. Agents Chemother. 57 (2013), 1040–1046.
13. Little, M., Seehaus, T., Comparative analysis of tubulin sequences. Comp. Biochem. Physiol. B: Comp. Biochem. 90 (1988), 655–670.
14. Mastrangelo, E., Pezzullo, M., De Burghgraeve, T., Kaptein, S., Pastorino, B., Dallmeier, K., de Lamballerie, X., Neyts, J., Hanson, A.M., Frick, D.N., Bolognesi, M., Milani, M., Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. J. Antimicrob. Chemother. 67 (2012), 1884–1894.
15. Schiff, P.B., Horwitz, S.B., Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. U. S. A. 77 (1980), 1561–1565.
16. Sharmeen, S., Skrtic, M., Sukhai, M.A., Hurren, R., Gronda, M., Wang, X., Fonseca, S.B., Sun, H., Wood, T.E., Ward, R., Minden, M.D., Batey, R.A., Datti, A., Wrana, J., Kelley, S.O., Schimmer, A.D., The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood 116 (2010), 3593–3603.